Home  »  Analyst Insights   »  Theravance Biopharma Inc. (TBPH) volume hits 1.06 ...

Theravance Biopharma Inc. (TBPH) volume hits 1.06 million: A New Opening for Investors

Theravance Biopharma Inc. (NASDAQ: TBPH) started the day on January 05, 2022, with a price decrease of -3.02% at $12.19. During the day, the stock rose to $12.75 and sunk to $12.19 before settling in for the price of $12.57 at the close. Taking a more long-term approach, TBPH posted a 52-week range of $6.10-$22.74.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


>> 7 Top Picks for the Post-Pandemic Economy << 

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 11.30%. Meanwhile, its Annual Earning per share during the time was 3.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -4.90%. This publicly-traded company’s shares outstanding now amounts to $73.57 million, simultaneously with a float of $60.55 million. The organization now has a market capitalization sitting at $892.67 million. At the time of writing, stock’s 50-day Moving Average stood at $9.23, while the 200-day Moving Average is $13.08.

While finding the extent of efficiency of the company that is accounted for 359 employees. It has generated 200,159 per worker during the last fiscal year. Meanwhile, its income per employee was -774,421. The stock had 1.20 Receivables turnover and 0.16 Total Asset turnover. For the Profitability, stocks operating margin was -414.37 and Pretax Margin of -398.76.

Theravance Biopharma Inc. (TBPH) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Theravance Biopharma Inc.’s current insider ownership accounts for 5.90%, in contrast to 84.60% institutional ownership. According to the most recent insider trade that took place on Mar 09, this organization’s SVP, Research & Transl Science sold 8,829 shares at the rate of 20.00, making the entire transaction reach 176,580 in total value, affecting insider ownership by 343,679.

Theravance Biopharma Inc. (TBPH) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 9/29/2021, the organization reported -$0.48 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.56) by $0.08. This company achieved a net margin of -386.90. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.

Theravance Biopharma Inc.’s EPS decrease for this current 12-month fiscal period is -4.90% and is forecasted to reach 0.35 in the upcoming year.

Theravance Biopharma Inc. (NASDAQ: TBPH) Trading Performance Indicators

Let’s observe the current performance indicators for Theravance Biopharma Inc. (TBPH). It’s Quick Ratio in the last reported quarter now stands at 4.50. The Stock has managed to achieve an average true range (ATR) of 0.73. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 15.10.

In the same vein, TBPH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.43, a figure that is expected to reach -0.01 in the next quarter, and analysts are predicting that it will be 0.35 at the market close of one year from today.

Technical Analysis of Theravance Biopharma Inc. (TBPH)

If we take a close look at the recent performances of Theravance Biopharma Inc. (NASDAQ: TBPH), its last 5-days Average volume was 2.02 million that shows plunge from its year to date volume of 2.89 million. During the previous 9 days, stock’s Stochastic %D was recorded 71.80% While, its Average True Range was 0.72.

>> 7 Top Picks for the Post-Pandemic Economy << 

Raw Stochastic average of Theravance Biopharma Inc. (TBPH) in the period of the previous 100 days is set at 74.45%, which indicates a major rise in contrast to 67.81% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 49.01% that was lower than 59.51% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam